These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hepatocellular Adenoma Subtypes Based on 2017 Classification System: Exploratory Study of Gadoxetate Disodium-Enhanced MRI Features With Proposal of a Diagnostic Algorithm. Tse JR; Felker ER; Cao JJ; Naini BV; Liang T; Lu DSK; Raman SS AJR Am J Roentgenol; 2023 Apr; 220(4):539-550. PubMed ID: 36169546 [No Abstract] [Full Text] [Related]
3. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Laumonier H; Bioulac-Sage P; Laurent C; Zucman-Rossi J; Balabaud C; Trillaud H Hepatology; 2008 Sep; 48(3):808-18. PubMed ID: 18688875 [TBL] [Abstract][Full Text] [Related]
4. Analysis of contrast-enhanced ultrasound features of hepatocellular adenoma according to different pathological molecular classifications. Chen K; Dong Y; Zhang W; Han H; Mao F; Zhang Q; Zheng Z; He W; Wang WP Clin Hemorheol Microcirc; 2020; 76(3):391-403. PubMed ID: 32675402 [TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience. Garcovich M; Faccia M; Meloni F; Bertolini E; de Sio I; Calabria G; Francica G; Vidili G; Riccardi L; Zocco MA; Ainora ME; Ponziani FR; De Gaetano AM; Gasbarrini A; Rapaccini GL; Pompili M J Ultrasound; 2019 Jun; 22(2):157-165. PubMed ID: 30306412 [TBL] [Abstract][Full Text] [Related]
6. Hepatocellular adenomas in the Turkish population: reclassification according to updated World Health Organization criteria. Deniz K; Umetsu SE; Ferrell L; Yılmaz F; Güllüoğlu M; Sağol Ö; Doğusoy GB; Kırımlıoğlu H; Turhan N; Doran F; Kepil N; Çelikel ÇA; Nart D; Özgüven BY; Ceyran B; Karadağ N; Kır G; Erden E; Yılmaz G; Akyol G Histopathology; 2021 Jul; 79(1):23-33. PubMed ID: 33406290 [TBL] [Abstract][Full Text] [Related]
7. Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma: correlation with MRI findings. Laumonier H; Cailliez H; Balabaud C; Possenti L; Zucman-Rossi J; Bioulac-Sage P; Trillaud H AJR Am J Roentgenol; 2012 Aug; 199(2):341-8. PubMed ID: 22826395 [TBL] [Abstract][Full Text] [Related]
8. Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. van Aalten SM; Thomeer MG; Terkivatan T; Dwarkasing RS; Verheij J; de Man RA; Ijzermans JN Radiology; 2011 Oct; 261(1):172-81. PubMed ID: 21875850 [TBL] [Abstract][Full Text] [Related]
9. Retrospective study of hepatocellular adenomas based on the phenotypic classification system: A report from China. Pan J; Chen L; Fan J; Zhou J; Qin L; Tan Y; Ji Y; Huang X Histol Histopathol; 2014 Feb; 29(2):243-9. PubMed ID: 23939475 [TBL] [Abstract][Full Text] [Related]
10. Hepatocellular adenomas: review of pathological and molecular features. Beaufrère A; Paradis V Hum Pathol; 2021 Jun; 112():128-137. PubMed ID: 33307077 [TBL] [Abstract][Full Text] [Related]
11. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Bioulac-Sage P; Laumonier H; Couchy G; Le Bail B; Sa Cunha A; Rullier A; Laurent C; Blanc JF; Cubel G; Trillaud H; Zucman-Rossi J; Balabaud C; Saric J Hepatology; 2009 Aug; 50(2):481-9. PubMed ID: 19585623 [TBL] [Abstract][Full Text] [Related]
12. Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation? Auer TA; Fehrenbach U; Grieser C; Penzkofer T; Geisel D; Schmelzle M; Müller T; Bläker H; Seehofer D; Denecke T Eur Radiol; 2020 Jun; 30(6):3497-3506. PubMed ID: 32086574 [TBL] [Abstract][Full Text] [Related]
13. Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification. Ronot M; Bahrami S; Calderaro J; Valla DC; Bedossa P; Belghiti J; Vilgrain V; Paradis V Hepatology; 2011 Apr; 53(4):1182-91. PubMed ID: 21480324 [TBL] [Abstract][Full Text] [Related]
14. Hepatocellular Adenomas: Morphology and Genomics. Bioulac-Sage P; Sempoux C; Balabaud C Gastroenterol Clin North Am; 2017 Jun; 46(2):253-272. PubMed ID: 28506364 [TBL] [Abstract][Full Text] [Related]
15. Subclassification of hepatocellular adenomas: practical considerations in the implementation of the Bordeaux criteria. Miller GC; Campbell CM; Manoharan B; Bryant R; Cavallucci D; O'Rourke N; Clouston AD Pathology; 2018 Oct; 50(6):593-599. PubMed ID: 30149989 [TBL] [Abstract][Full Text] [Related]
17. Limited added value of contrast-enhanced ultrasound over B-mode for the subtyping of hepatocellular adenomas. Gregory J; Paisant A; Paulatto L; Raynaud L; Bertin C; Kerbaol A; Vullierme MP; Paradis V; Vilgrain V; Ronot M Eur J Radiol; 2020 Jul; 128():109027. PubMed ID: 32361381 [TBL] [Abstract][Full Text] [Related]
18. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Bioulac-Sage P; Rebouissou S; Thomas C; Blanc JF; Saric J; Sa Cunha A; Rullier A; Cubel G; Couchy G; Imbeaud S; Balabaud C; Zucman-Rossi J Hepatology; 2007 Sep; 46(3):740-8. PubMed ID: 17663417 [TBL] [Abstract][Full Text] [Related]
19. MR imaging of hepatocellular adenomas on genotype-phenotype classification: A report from China. Wang H; Yang C; Rao S; Ji Y; Han J; Sheng R; Zeng M Eur J Radiol; 2018 Mar; 100():135-141. PubMed ID: 29496071 [TBL] [Abstract][Full Text] [Related]
20. Hepatocellular adenoma: An unsolved diagnostic enigma. Renzulli M; Clemente A; Tovoli F; Cappabianca S; Bolondi L; Golfieri R World J Gastroenterol; 2019 May; 25(20):2442-2449. PubMed ID: 31171888 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]